alexa Pulmonary Delivery Of A Mucosal Nanocarrier Vaccine For Pneumonia
ISSN: 2157-7560

Journal of Vaccines & Vaccination
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

15th Annual Summit on Vaccines and Immunization
February 20-21, 2017 Berlin, Germany

Imran Saleem
Liverpool John Moores University, UK
ScientificTracks Abstracts: J Vaccines Vaccin
DOI: 10.4172/2157-7560.C1.054
Abstract
Statement of the Problem: There is a huge drive in the vaccine research field, pharmaceutical industry and Bill Gates Foundation for effective targeting of dendritic cells (DCs) to enhance the immune response and for needle-free vaccination. The pulmonary route has an abundance of antigen presenting cells (such as macrophages, DCs) for targeting vaccines. Furthermore, nanoparticles (NPs) due to their size can target DCs enhancing the immune response. However, NPs have poor aerosolization performance as dry powders. Aim: The aim of this study was to compare encapsulated and adsorbed pneumococcal protein (PspA), onto poly(glycerol adipateco- ω-pentadecalactone), PGA-co-PDL, NPs to target lung DCs. Further to formulate these NPs into dry powder, nanocomposite microparticles (NCMPs) were suitable for pulmonary vaccine delivery. Methodology & Theoretical Orientation: NPs were prepared using an emulsion solvent evaporation method and PspA was adsorbed (F1) onto the surface of NPs or encapsulated (F2) (100: 20 [NP: PspA]). F1 and F2 were spray-dried in an aqueous suspension of leucine (1:1.5) to produce NCMPs and characterized in terms of particle size, loading, cell viability, protein stability (SDS-PAGE), integrity (circular dichroism, CD), antigenicity (ELISA), aerosolization studies and lung immunization in mice. Conclusion & Significance: F1 and F2 produced similar size NPs but the PspA loading was significantly greater in F2 (310.4±25.3 nm, 65.73±5.6 μg/mg) compared to F1 (322.83±4.25 nm, 19.68±2.74 μg/mg). F1 had FPF% >75%. The NPs appear to be well tolerated by DCs cell lines (F1 and F2 NPs ≥90% cell viability) at 19.5 μg/mL after 4 h exposure. The antigenicity (>95%) confirmed that PspA was stable in both formulations after spray-drying. F1 induced an earlier control of the infection with lower bacterial load in the lungs after challenge. The results provide an indication that it may be feasible to use these NPs/NCMPs carriers containing protein antigens for pulmonary vaccine delivery against lung infection with pneumococci.
Biography

Imran Saleem is a Reader in Nanomedicine at Liverpool John Moores University, UK. His research interest includes “Developing novel delivery systems for targeting therapeutic agents to their site of action, with particular emphasis on lung diseases via dry powder pulmonary delivery”. He has over 10 years of experience in the area of Micro/Nanoparticle Formulation and Drug Delivery Systems, and has published extensively in peer-reviewed journals, conference abstracts and book chapters. His research group is focused on “The design and development of carriers for delivery of bio-macromolecules including vaccines and drugs”. Currently, his research group is working on the design and development of nanocarriers for pulmonary delivery of pneumococcal vaccine, gene delivery for treatment of COPD and lung cancer. He is currently investigating nanoparticle (NPs) delivery systems and manufacturing nanocomposite micro-particle carriers (NCMPs) for pulmonary delivery.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords